A better strategic information for effecctive HIV - AIDS response in Indonesia   

Pilih Bahasa
(Select Interface Language)

English Indonesian
Untuk Akses, Mohon Registrasi

Daftar Member Baru - Login Member
    HIV-tuberculosis co-infection is a global problem: resources need to be expanded and funding must be sustainable and predictable        PB IDI menyatakan bahwa kondom adalah alat kesehatan yang mampu mencegah penularan infeksi menular seksual (termasuk HIV) bila digunakan pada setiap kegiatan seks berisiko.        By enabling and empowering women to protect themselves and their partners with female condoms, we can begin saving lives and curbing the spread of HIV today.         Women need prevention now. They need access to the female condom and education on its use.        Indonesian AIDS Community (AIDS-INA) will use internet technologies for facilitating the dissemination and exchange of knowledge and experience in HIV/AIDS programme among all community members        Do you know that DFID provide £25 million in support of a large HIV and AIDS Programme in Indonesia started in 2005? Do you know where the fund have been allocated?        Apakah Menko KesRa atau Presiden SBY masih peduli terhadap penanggulangan penyakit menular, termasuk HIV-AIDS, TB, Malaria - di Indonesia? Indonesia sedang dalam kondisi sungguh sulit dengan dampak penularan yang terus meluas pada masyarakat yang miskin        Bila Konsep Akselerasi Upaya Penanggulangan HIV-AIDS di Indonesia tidak difahami dengan BENAR dan Berbasis evidence, maka TIDAK AKAN berhasil menahan laju epidemi HIV di Indonesia. Itu yang terjadi sekarang!        Further evidence to support a recommendation for exclusive breastfeeding by HIV-positive mothers in resource-limited settings        Deliver TB and HIV services in the context of fully functioning primary health care systems to ensure cases are detected, prevention is available and treatment accessible and sustained        Reach the most vulnerable populations with TB and HIV services Now!        The HIV service providers need to do : screening for TB and starting isoniazid preventive therapy if there is no sign of active TB.        To fight AIDS we must do more to fight TB (Nelson Mandella, 2004)        Violence makes women more susceptible to HIV infection and the fear of violent male reactions, physical and psychological, prevents many women from trying to find out more about it, discourages them from getting tested and stops them from getting treatmen        People at high risk of HIV exposure should be tested every three to six months in identifying recently infected people then we have to be able to counsel them to modify high-risk sexual behavior and desist from transmitting the virus        About half of new HIV cases occur when the person transmitting the virus is in the early stages of infection and unlikely to know if he or she is HIV-positive        HIV/AIDS Epidemic in Indonesia: not one ( single) epidemic but many (multiple) (riono, pandu)        Combating HIV-AIDS requires more than prevention and treatment. It requires improving the conditions under which people are free to choose safer life strategies and conditions.        Para pecandu yang butuh alat suntik (insul) steril, hubungi LSM setempat - Lihat pada Jejaring Layanan        Kurangi Dampak Akibat Bencana Napza dengan Upaya Pemulihan Pecandu yang komprehensif (metadon, Jarums steril, tes HIV dan Hep C, Pengobatan dan Dukungan)        Treatment without prevention is simply unsustainable! Pengobatan saja tanpa upaya pencegahan yang serius dan sistematik sama saja BOHONG!        1 Desember: keprihatinan global atas kegagalan kita!        Gunakan alat suntik steril untuk hindari penularan HIV dan Hepatitis        Pakai kondom pada setiap kegiatan seks berisiko, dapat mencegah penularan HIV        HIV tidak mudah menular dari satu orang ke orang lain        Komisi Penanggulangan AIDS (KPA) adalah institusi koordinasi BUKAN Pelaksana program atau Implementor!!        Profesi Kesehatan perlu terlibat dan dilibatkan secara aktif dalam upaya penanggulangan HIV-AIDS        Perluasan Masalah HIV-AIDS di Indonesia TIDAK mungkin dibatasi oleh wilayah administratif tertentu saja        Hindari diskriminasi dan stigmatisasi pada orang rawan dan orang yang telah terkena HIV        AIDS adalah kenyataan, lakukan tes HIV bila ingin tahu status anda        AIDS-INA - Sarana komunitas AIDS Indonesia untuk menyampaikan gagasan serta tukar informasi    


 Data Kasus
 Daftar Istilah

 Layanan AIDS
 Laporan Keg.


Informasi Dasar
  Harm Reduction
  Tes HIV

Translate with
Google Translate

Lilin Kenangan

Lilin Kenangan
Lilin Kenangan dipersembahkan untuk:
""miracle" dengan segala kondisi dan keadaan yang terjadi, tetaplah bersamanya "miracle" . harapan-harapan yang terjadi tidaklah membuat berhenti untuk hidup ini. untuk yang tinggal dan pergi, smua akan terasa "miracle" bertahan dan hidup, bertahan dan tertidur, bertahan dan kembali padanya. harapan akan segalanya. "miracle""
ester rini lestari
Jawa Tengah

Nyalakan Lilin Anda

Partisipasi Anda

 Umpan Balik
 Kirim Kegiatan
 Kirim berita
 Join Mailist aids-ina



Yang sedang online

Saat ini ada
121 tamu, 0 anggota
Hari ini dikunjungi oleh 835 tamu/anggota


Site ini telah dikunjungi
29204284 kali
sejak August 2006

Donation & Report

AIDsina Production: for Healthly Community
Bangun Informasi AIDS untuk Semua Bersama Kami!
Bangun Informasi AIDS untuk Semua Bersama Kami!


Republik Indonesia

Departemen Kesehatan RI

AIDS Data Hub

Komisi Penanggulangan AIDS Nasional

Ikatan Dokter Indonesia

Power by
PHP Nuke

[ Halaman Utama Download | Baru | Populer ]

Kategori: Utama/Jurnal Ilmiah

Urutkan berdasarkan: Judul (A\D) Tanggal (A\D) Nilai (A\D) Popularitas (A\D)
Saat ini ditampilkan menurut: Judul (A - Z)

  Pilot study for TB-HIV co-infection prevalence survey in Indonesia 
Deskripsi: Objective: To pilot and assess acceptability of unlinked anonymous testing and potential uptake of Voluntary Counselling and Testing (VCT) among tuberculosis (TB) patients in Jogjakarta, Indonesia and determine HIV prevalence among TB patients in the pilot area,
Method: We introduced unlinked anonymous HIV testing for TB patients attending Directly Observed Treatment, Short-course (DOTS) services between April-December 2006. Demographic characteristics were documented for all patients. Patients were additionally offered access to free VCT services. We used logistic regression to identify risk factors for HIV-positive test and for VCT non-interest.
Results: There were 1681 TB patients registered during the study period. Out of these, 989 (58.8%) accepted and undertook unlinked anonymous testing. The acceptance rate of unlinked anonymous testing among those who were offered was 77.9%. There were no significant differences between the two groups apart from districts. HIV prevalence in all TB tested patients was 1.9 (95% CI 1.6-2.2). Out of those offered VCT, 856 (86.6%) were not interested.
Conclusion: The prevalence of HIV among TB patients is higher than WHO estimate for Indonesia. There was high acceptance rate to unlinked anonymous testing and low interest toward VCT.

Bila menginginkan file dapat diunduh dengan klik disini

Ukuran file: 0 bytes
Dimasukkan: 30-Oct-2007
Downloand: 130

  Self-reported side-effects of anti-retroviral treatment among IDUs: A 7-year longitudinal study 
Deskripsi: Abstract
The introduction of potent anti-retroviral treatment (ART) has transformed HIV disease into a chronic condition with the prospect, for the patient, of strict adherence to effective but life-long treatments. Within this framework, a major issue that can negatively affect adherence is the side-effects of the treatment. To date, studies documenting how individuals HIV-infected through drug injection (IDUs) experience ART-related side effects are sparse.

Longitudinal data collected from the APROCO-COPILOTE cohort have been used to compare the experience of ART-related side-effects who have been HIV-infected via injecting drug use and non-IDU patients. A 20-item list was used to collect self-reported side-effects over a 7-year follow up period.

Of 922 patients, 15% were IDUs. At any given visit, IDUs reported a signi?cantly higher number of side-effects and had approximately twice the risk of reporting any side effect than non-IDUs. Most commonly reported side-effects were dry skin, fatigue, vomiting, bone troubles, insomnia. After adjustment for social conditions, depressive symptoms, use of sleeping pills and time since HIV diagnosis, IDUs reported experiencing signi?cantly more side-effects than non-IDUs. Whether or not this is related to sensitivity to pain or to other comorbidities is dif?cult to establish.

Further research is needed to understand how substitution treatment can mediate the relationship between exposure to opioids and side¬effects. Providing appropriate care to reduce side-effects, thereby increasing adherence to ART in this population, remains a major challenge especially in those countries scaling up ART. Incorporating symptom management and improving access to analgesic medications within a model of comprehensive care for HIV-infected IDUs, could reduce the impact of drug-related and HIV-related harms and induce better long-term treatment outcomes and quality of life. © 2007 Elsevier B.V. All rights reserved.

Keywords: Side effects; Anti-retroviral treatment; HIV; Injecting drug users; Hyperalgesia; Pain
Ukuran file: 0 bytes
Dimasukkan: 28-Sep-2007
Downloand: 97

  Universal access to HIV/AIDS treatment for injecting drug users: Keeping the promise 
Deskripsi: The introduction of highly active antiretroviral therapy (ART) in the mid-1990s brought new hope for people living with HIV/AIDS. ART promised to make a fatal disease a manageable chronic illness. In the early years access to such treatment was limited to those living in rich countries. The cost of medicines was prohibitive for most, the treatment regimens were complex with multiple side effects, treatment needed to be monitored by specialised physicians with access to sophisticated laboratories and other health services, and patients needed to be living in stable and supportive environments. Any belief that treatment was only feasible for the rich and privileged was shattered in 1997 when Brazil became the ?rst developing country to provide ART through its public health system.

Despite the leadership of Brazil few other developing countries (exceptions included such countries as Argentina, Botswana, Chile, Senegal, Uganda and Thailand) committed to a similar public health response thereafter. As HIV-related mortality and morbidity plummeted in most high-income countries with the rapid expansion of ART, ever-increasing numbers of people were dying in low-and middle-income countries. Such disparities in access to life-saving treatment galvanised a global movement in support of rapid treatment scale up. On 22 September 2003, the World Health Organization (WHO), the UNAIDS Secretariat, and The Global Fund to Fight AIDS, Tuberculosis and Malaria declared the lack of access to ART as a global health emergency. In response, WHO and the UNAIDS Secretariat announced a global target to provide ART to three million people in low-and middleincome countries by 2005, the “3 by 5” target. A multi-partner response followed in many countries, involving governments, civil society, technical agencies and donors. In the 2 years of the initiative those receiving ART in low-and middleincome countries increased from an estimated 400,000 at the end of 2003 to 1.3 million by the end of 2005 (WHO, 2006). The success of “3 by 5” did much to mobilise political commitment for treatment scale-up, leading to a declaration from G8 leaders in July 2005 to support countries to scale
Ukuran file: 0 bytes
Dimasukkan: 27-Sep-2007
Downloand: 95

Pilih Halaman:   [ << Sebelumnya ] 1 2 
    ilahi Komunitas AIDS Indonesia - Indonesian AIDS Community
To Facilitate a Network for HIV-AIDS Worker in Indonesia